ADOC — Adocia SA Share News
0.000.00%
Last trade - 00:00- €51.42m
- €49.35m
- €1.48m
Brief: Adocia FY Operating Revenue Down At 27.2 Million Euros
Brief: Adocia Files Additional Arbitration Claims Against Eli Lilly & Company
Brief: Adocia Announces Positive Topline Data From Study Of Biochaperone
Europe Research Roundup: Amadeus, Amadeus, Randstad Holding
Brief: Adocia Announces Expanded Biochaperone Product Portfolio Beyond Diabetes
Brief: Adocia Announces Positive Topline Study Results
French and Benelux stocks-Factors to watch on Nov 21
Brief: Adocia reports topline results of Biochaperone Glucagon Phase 1 study
Brief: Adocia 9-month revenue at 19.6 million euros
Europe Research Roundup: Tullow Oil Plc, Vivendi, Wincanton Plc
Brief: Adocia appoints Dr. Stanislav Glezer as Chief Medical Officer
Brief: Adocia H1 net result turns to profit of 7.1 million euros
Brief: Adocia Q1 revenue rises to 19.4 million euros
Brief: Adocia FY net result turns to loss of 7.9 million euros
Brief: Adocia 2016 revenue down at 22.4 million euros
Brief: Adocia says Eli Lilly terminates collaboration biochaperone Lispro
Brief: Adocia, given its cash position, clarifies that no capital increase is being considered
Brief: Adocia announces two projects for the treatment of type 1 diabetes
Brief: Adocia and Lilly announce successful completion of an insulin pump study with BioChaperone Lispro in people with type 1 diabetes